EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CSF Cytokine Network Organization Predicts Progression Independent of Relapse and MRI Activity in Multiple Sclerosis

Antonio Bruno, Matteo Conti iD, Ettore Dolcetti, Federica Azzolini, Angela Borrelli, Roberta Fantozzi, Mario Stampanoni Bassi, Giovanni Galifi, Giuseppe Maccarrone, Luca Montaguti, Marco Cervigni, Maddalena Dal Pozzo und 8 weitere

Annals of Clinical and Translational Neurology · 19.08.2026

DOI: 10.1002/acn3.70502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 19.08.2026. Verfasst von Antonio Bruno und 19 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Neuromed, Pozzilli, (IS), Italy. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero Della Salute, Ministero dell'Università e Della Ricerca, "5 per mille" public funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Progression independent of relapse activity is a major determinant of long‐term disability in multiple sclerosis, but its immunopathologic basis remains incompletely understood. We investigated whether relapse‐independent progression in radiologically stable relapsing–remitting multiple sclerosis is associated with distinct cerebrospinal fluid inflammatory profiles and whether cytokine‐network features provide information beyond single‐mediator levels.

Methods

In this prospective observational cohort study, baseline cerebrospinal fluid cytokine and chemokine profiling was performed in 346 RRMS patients, 61 primary progressive multiple sclerosis (PPMS) patients, and 196 neurological controls without inflammatory or neurodegenerative central nervous system disease. After 2‐year clinical and MRI follow‐up, 37 RRMS patients with clinical relapse and/or MRI activity were excluded, leaving 309 relapse‐free and MRI‐stable RRMS patients classified as stable RRMS ( n = 241) or RRMS with PIRMA ( n = 68). Cytokines were analyzed using two‐part hurdle models, cytokine interactomes, and machine‐learning classifiers.

Results

Quantitative cytokine analyses distinguished multiple sclerosis from controls but showed substantial overlap across multiple sclerosis phenotypes. RRMS with PIRMA showed higher cerebrospinal fluid levels of tumor necrosis factor‐α, interleukin‐17, and RANTES than stable RRMS. Network analyses showed a more integrated cytokine interactome in RRMS with PIRMA. The network‐level model best distinguished RRMS with PIRMA from stable RRMS, with an area under the curve of 0.86, sensitivity of 77%, and specificity of 76%.

Interpretation

Relapse‐independent progression in multiple sclerosis is associated with selective cytokine changes and broader reorganization of inflammatory network architecture, supporting cerebrospinal fluid cytokine interactome profiling as a translational approach to immune stratification.

Schlagwörter

Stichwörter der Autor:innen

PIRMAautoimmunitycytokinesmultiple sclerosisneuroinflammation

Autor:innen und Institutionen

  • IRCCS Neuromed, Pozzilli, (IS), Italy.
  • Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Faculty of Psychology, Uninettuno Telematic International University, Rome, Italy.
  • Clinica Neurologica, Azienda Ospedaliero Universitaria Delle Marche, Università Politecnica Delle Marche, Ancona, Italy.
  • Clinical Neuroimmunology Unit, Institute of Experimental Neurology (INSpe), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
  • Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.

ORCID-Profile: Matteo Conti, Roberto Furlan, Antonella Conte, Diego Centonze

Förderung

  • Ministero Della Salute
  • Ministero dell'Università e Della Ricerca
  • "5 per mille" public funding
  • Fondazione Italiana Sclerosi Multipla

Zitieren

APA

Bruno, A., Conti, M., Dolcetti, E., Azzolini, F., Borrelli, A., Fantozzi, R., Stampanoni Bassi, M., Galifi, G., Maccarrone, G., Montaguti, L., Cervigni, M., Pozzo, M. D., Furlan, R., Finardi, A., Marfia, G. A., Salvetti, M., Conte, A., Buttari, F., Centonze, D., & Gilio, L. (2026). CSF Cytokine Network Organization Predicts Progression Independent of Relapse and MRI Activity in Multiple Sclerosis. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70502

Vancouver

Bruno A, Conti M, Dolcetti E, Azzolini F, Borrelli A, Fantozzi R, et al. CSF Cytokine Network Organization Predicts Progression Independent of Relapse and MRI Activity in Multiple Sclerosis. Annals of Clinical and Translational Neurology. 2026. doi:10.1002/acn3.70502

BibTeX
@article{Bruno2026,
  author = {Bruno, Antonio and Conti, Matteo and Dolcetti, Ettore and Azzolini, Federica and Borrelli, Angela and Fantozzi, Roberta and Stampanoni Bassi, Mario and Galifi, Giovanni and Maccarrone, Giuseppe and Montaguti, Luca and Cervigni, Marco and Pozzo, Maddalena Dal and Furlan, Roberto and Finardi, Annamaria and Marfia, Girolama Alessandra and Salvetti, Marco and Conte, Antonella and Buttari, Fabio and Centonze, Diego and Gilio, Luana},
  title = {CSF Cytokine Network Organization Predicts Progression Independent of Relapse and MRI Activity in Multiple Sclerosis},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2026},
  doi = {10.1002/acn3.70502}
}
Kostenlos starten →